Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Finished Goods (2023 - 2025)

Profound Medical has reported Finished Goods over the past 3 years, most recently at $5.3 million for Q4 2025.

  • Quarterly results put Finished Goods at $5.3 million for Q4 2025, up 37.61% from a year ago — trailing twelve months through Dec 2025 was $5.3 million (up 37.61% YoY), and the annual figure for FY2025 was $5.3 million, up 37.61%.
  • Finished Goods for Q4 2025 was $5.3 million at Profound Medical, down from $5.8 million in the prior quarter.
  • Over the last five years, Finished Goods for PROF hit a ceiling of $5.8 million in Q3 2025 and a floor of $3.8 million in Q4 2024.
  • Median Finished Goods over the past 3 years was $5.0 million (2023), compared with a mean of $5.0 million.
  • Biggest five-year swings in Finished Goods: decreased 17.27% in 2024 and later skyrocketed 37.61% in 2025.
  • Profound Medical's Finished Goods stood at $4.6 million in 2023, then decreased by 17.27% to $3.8 million in 2024, then skyrocketed by 37.61% to $5.3 million in 2025.
  • The last three reported values for Finished Goods were $5.3 million (Q4 2025), $5.8 million (Q3 2025), and $5.6 million (Q2 2025) per Business Quant data.